跳至主要内容
临床试验/NL-OMON53593
NL-OMON53593招募中4 期

Preoperative sodium glucose cotransporter 2 inhibitors for prevention of postoperative acute kidney injury in cardiac surgery patients - a randomized, placebo-controlled, multi-centre, phase IV clinical trial - The MERCURI-2 trail

Academisch Medisch Centrum0 个研究点目标入组 784 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
入组人数
784

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. >18 years old 2. Undergoing elective cardiac surgery. 3. Providing informed

排除标准

  • 1. Current treatment with SGLT2 inhibitors 2. Reduced kidney function at
  • baseline with eGFR < 20 ml/min at time of inclusion 3. Diabetes Mellitus Type 1
  • 4. History of diabetic keto acidosis 5. Diabetes Mellitus Type 2 with BMI<25
  • for people with type 2 diabetes who are using multiple daily insulin injections
  • (both short and long-acting insulin) 6. Systolic blood pressure < 100 mmHg at
  • time of inclusion 7. Emergency surgery, defined as in need of surgery for
  • medical reasons < 7 days, i.e. *S1-4* according to the Amsterdam UMC
  • classification 8. Female of child-bearing potential who is pregnant,
  • breast-feeding or intend to become pregnant or is not using adequate
  • contraceptive methods 9. Known or suspected allergy to trial products or other
  • drugs in the same class

研究者

相似试验

Preoperative sodium glucose cotransporter 2... | 临床试验